Clinical trial supply planning brings several timelines together: the study schedule, site readiness, sourcing lead time, product expiry and the time needed to prepare a controlled handover. When those timelines are discussed separately, a request can appear simpler than it is.
The first planning conversation does not need to solve every dependency. Its purpose is to make the important questions visible early enough to be managed.
1. What exactly must be sourced?
Comparator identity should be described as precisely as the study requirement allows. Product name alone may not distinguish strength, dosage form, pack, presentation or market-specific configuration.
If the requirement permits alternatives, state which characteristics are fixed and which can be evaluated. Do not substitute an assumption for a protocol or sponsor decision.
2. Where and when will the supply be used?
Countries, sites and the expected study timeline shape the supply plan. The relevant question is not only the final delivery date, but also when the receiving site can accept, check and store the shipment.
Planning should separate confirmed dates from provisional milestones. This makes it easier to identify where changes in enrolment or site activation may affect demand.
3. How was the quantity estimated?
An initial quantity can be influenced by the number of sites, expected recruitment, treatment schedule, resupply approach, pack size and contingency. The supply partner does not need confidential patient information to understand the operational assumption.
Record which inputs are confirmed and which may change. Where several scenarios exist, a range can be more honest and more useful than a single unsupported number.
4. What expiry profile is workable?
Availability and usable shelf life are different questions. A product may be sourceable but unsuitable for the intended study window once preparation, transport, site receipt and expected use are considered.
Define the minimum remaining shelf life or latest acceptable expiry date as early as possible. If staggered delivery or resupply could reduce expiry risk, make that option visible during planning.
5. Which storage and transport conditions apply?
Temperature requirements need to be treated as part of the product specification, not as a logistics note added after sourcing. Clarify known storage range, transport controls, monitoring expectations and what the receiving site needs at handover.
If the requirement is not yet confirmed, label it as an open technical question so that the route is not designed around an unverified condition.
6. Which information and documents must move with the product?
The expected documentation can vary by study, product, market, parties and delivery model. Build a request-specific document list with the responsible stakeholders instead of assuming that one standard pack will fit every movement.
Version and ownership matter. A clear list should state who provides each item, when it is needed and which version is current.
Turn the answers into one connected planning brief
A useful early brief can be organised under six headings:
- exact product or comparator identity;
- countries, sites and study timing;
- quantity assumptions and change drivers;
- minimum shelf-life expectation;
- storage, transport and monitoring conditions; and
- required information, documents and responsible parties.
Add a short risk-and-dependency section. It should show which open point could change the quantity, route or delivery window, and who is expected to resolve it.
This article describes operational scoping questions. It does not replace the study protocol, sponsor procedures, qualified specialist review or applicable legal and regulatory requirements.